Page 24 - GPD-2-2

Gene & Protein in Disease MOR in cancer

421–428. in the nucleus is a novel prognostic factor of esophageal
115. Zagon IS, McLaughlin PJ, 2014, Opioid growth factor and squamous cell carcinoma. Hum Pathol, 44(9): 1756–1765.
the treatment of human pancreatic cancer: A review. World
J Gastroenterol, 20(9): 2218–2223. https://doi.org/10.1016/j.humpath.2012.11.025
https://doi.org/10.3748/wjg.v20.i9.2218 125. Xie N, Matigian N, Vithanage T, et al., 2018, Effect of
perioperative opioids on cancer-relevant circulating
116. Kim JY, Ahn HJ, Kim JK, et al., 2016, Morphine suppresses
lung cancer cell proliferation through the interaction with parameters: Mu opioid receptor and toll-like receptor 4
opioid growth factor receptor: An in vitro and human lung activation potential, and proteolytic profile. Clin Cancer Res,
tissue study. Anesth Analg, 123(3): 1429–1436. 24(10): 2319–2327.
117. Ma Y, Ren Z, Ma S, et al., 2017, Morphine enhances renal
cell carcinoma aggressiveness through promotes survivin https://doi.org/10.1158/1078-0432.CCR-18-0172
level. Ren Fail, 39(1): 258–64. 126. Fu J, Xu M, Xu L, et al., 2021, Sulforaphane alleviates
118. Belltall A, Zúñiga-Trejos S, Garrido-Cano I, et al., 2022, hyperalgesia and enhances analgesic potency of morphine
Solid tumor opioid receptor expression and oncologic in rats with cancer-induced bone pain. Eur J Pharmacol,
outcomes: Analysis of the cancer genome atlas and genotype 909: 174412.
tissue expression project. Front Oncol, 12: 801411.
https://doi.org/10.3389/fonc.2022.801411 https://doi.org/10.1016/j.ejphar.2021.174412
119. Zhang H, Qu M, Gorur A, et al., 2021, Association of 127. Maher DP, Wong W, White PF, et al., 2014, Association of
Mu-opioid receptor(MOR) expression and opioids increased postoperative opioid administration with non-
requirement with survival in patients with stage I-III small-cell lung cancer recurrence: A retrospective analysis.
pancreatic ductal adenocarcinoma. Front Oncol, 11: 686877.
Br J Anaesth, 113 Suppl 1: i88–i94.
https://doi.org/10.3389/fonc.2021.686877
https://doi.org/10.1093/bja/aeu192
120. Díaz-Cambronero O, Mazzinari G, Giner F, et al., 2020,
Mu opioid receptor 1 (MOR-1) expression in colorectal 128. Szczepaniak A, Fichna J, Zielińska M, 2022, Opioids in
cancer and oncological long-term outcomes: A five-year cancer development, progression and metastasis: Focus on
retrospective longitudinal cohort study. Cancers (Basel),
12(1): 134. colorectal cancer. Curr Treat Options Oncol, 21(1): 6.
https://doi.org/10.3390/cancers12010134 https://doi.org/10.1007/s11864-019-0699-1
121. Wang H, Luo J, Chen X, et al., 2022, Clinical observation of 129. Cadet P, Rasmussen M, Zhu W, et al., 2004, Endogenous
the effects of oral opioid on inflammatory cytokines and gut morphinergic signaling and tumor growth. Front Biosci,
microbiota in patients with moderate to severe cancer pain:
A retrospective cohort study. Pain Ther, 11(2): 667–681. 9: 3176–3186.
https://doi.org/10.1007/s40122-022-00386-w https://doi.org/10.2741/1471
122. Edwards KA, Havelin JJ, Mcintosh MI, et al., 2018, A kappa 130. Tan M, Wang H, Gao C, et al., Agonists specific for kappa-
opioid receptor agonist blocks bone cancer pain without opioid receptor induces apoptosis of HCC cells through
altering bone loss, tumor size, or cancer cell proliferation in
a mouse model of cancer-induced bone pain. J Pain, 19(6): enhanced endoplasmic reticulum stress. Front Oncol,
612–625. 12: 844214.
https://doi.org/10.1016/j.jpain.2018.01.002 https://doi.org/10.3389/fonc.2022.844214
123. Huang HM, He XH, Huang XY, et al., 2022, Down- 131. Lin ZZ, Bo N, Fan YC, et al., 2022, Xanthomicrol suppresses
regulation of kappa opioid receptor promotes ESCC
proliferation, invasion and metastasis via the PDK1-AKT human hepatocellular carcinoma cells migration and
signaling pathway. Cell Commun Signal, 20(1): 35. invasion ability via Μu-opioid receptor. J Pharm Pharmacol,
https://doi.org/10.1186/s12964-022-00833-3 74(1): 139–146.
124. Zhang YF, Xu QX, Liao LD, et al., 2013, κ-Opioid receptor https://doi.org/10.1093/jpp/rgab104

Volume 2 Issue 2 (2023) 18 https://doi.org/10.36922/gpd.282